RecallDepth
Class II Completed

Ranitidine Tablets, USP 150 mg, a.) 65 count bottles (NDC 49035-404-61) b.) 130 count bottles (NDC 49035-404-13) c.) 220 count bottles (NDC 49035-404-65) (Walmart) OTC

Company
Dr. Reddy'S Laboratories, Inc.
Recall Initiated
October 1, 2019
Posted
November 13, 2019
Recall Number
D-0171-2020
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Princeton, NJ, United States

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Distribution

Product was distributed to major distributors throughout the United States who may have further distributed the product.

Lot / Code Info

Batch Numbers: All lots within expiry.

More recalls by Dr. Reddy'S Laboratories, Inc.

View all recalls by this company →

Other recent Class II Drug recalls